✦ LIBER ✦

Death receptors and melanoma resistance to apoptosis

✍ Scribed by Ivanov, Vladimir N; Bhoumik, Anindita; Ronai, Ze'ev

Book ID: 110067563
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 194 KB
Volume: 22
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1206456

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DEATH AND ANTI-DEATH: TUMOUR RESISTANCE

DEATH AND ANTI-DEATH: TUMOUR RESISTANCE TO APOPTOSIS

✍ Igney, Frederik H.; Krammer, Peter H. 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 282 KB

Death and decoy receptors and p53-mediat

Death and decoy receptors and p53-mediated apoptosis

✍ Sheikh, M S; Fornace, A J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Tissue inhibitor of metalloproteinases-3

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors

✍ Ahonen, Matti; Poukkula, Minna; Baker, Andrew H; Kashiwagi, Masahide; Nagase, Hi 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 615 KB

TRAIL and apoptosis induction by TNF-fam

TRAIL and apoptosis induction by TNF-family death receptors

✍ Wang, Shulin; El-Deiry, Wafik S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

Rescue of death receptor and mitochondri

Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo

✍ Stella Okouoyo; Kerstin Herzer; Esat Ucur; Jürgen Mattern; Peter H. Krammer; Kla 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 1004 KB

## Abstract Non small cell lung carcinoma (NSCLC) is a highly lethal malignancy that often becomes resistant to chemotherapy. To determine whether alterations in apoptotic signaling might contribute to such resistance, we established __in vitro__ and __in vivo__ models for sensitive and resistant h

Tumor resistance to apoptosis

✍ Simone Fulda 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 119 KB

## Abstract One of the hallmarks of human cancers is the intrinsic or acquired resistance to apoptosis. Evasion of apoptosis may contribute to carcinogenesis, tumor progression and also to treatment resistance, since most current anticancer therapies including chemotherapy, radio‐ and immunotherapy